We are live on ! Find out more
ONTXW

Onconova Therapeutics, Inc. Warrants
ONTXW

Delisted

ONTXW was delisted on the 23rd of July, 2021.

Back to rankings

7 hedge funds and large institutions have $611K invested in Onconova Therapeutics, Inc. Warrants in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

40% more funds holding

Funds holding: 5 → 7 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $634K → $611K (-$23K)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$749K
2
SM
Sabby Management
Florida
+$4.04K
3
LYV
Live Your Vision
Pennsylvania
+$2.07K
4
UBS Group
UBS Group
Switzerland
+$1.12K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$61K

ONTXW Hedge Fund Activity: Q1 2018 in Review

7 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q1 2018, worth a combined $611K — down 3.6% from $634K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ONTXW positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $749K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $61K sold.

  • 7 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q1 2018, up from 5 in Q4 2017.
  • Funds reported $611K of Onconova Therapeutics, Inc. Warrants stock for Q1 2018, down 3.6% quarter-over-quarter.
  • 3 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q1 2018 and 1 closed out, a net change of +2 holders.
  • The largest Onconova Therapeutics, Inc. Warrants buyer in Q1 2018 was 683 Capital Management, an estimated $749K added.
  • The largest Onconova Therapeutics, Inc. Warrants seller in Q1 2018 was Susquehanna International Group, an estimated $61K sold.

Based on aggregated 13F filings for Q1 2018.